Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for complications after pancreaticoduodenectomy
NCT05567094Phase 4Completed
- Sponsor
- Ruijin Hospital
- Start
- Oct 2022
- Primary completion
- Sep 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative complications comparing Dexamethasone with Placebo (2 arms). Primary endpoint: Comprehensive Complication Index at 30 days. Started Oct 2022; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative complications
Beyond the preview
Go deeper on NCT05567094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05567094.